women.
Causes: anatomy and
certain behavioral factors, including delays in micturition, sexual activity, and the use of diaphragms and spermicides tract.
Aggressive diagnostic
work-ups are unwarranted in young women presenting with an uncomplicated episode of cystitis.
to a few pathogens.
70%- 85% are caused by
Escherichia coli
5-20%are caused by
Fever >38C, flank pain, costovertebral angle tenderness, and nausea or vomiting suggest upper tract infection.
STDs, new sexual partner, partner with urethral symptoms, gradual onset.
recommend empiric antibiotic tx. Unnecessary antibiotic use?? Clinical criteria for Dx:
Dysuria, presence of > trace urine leukocytes, and presence of nitrites or... Dysuria and frequency in the absence of vaginal discharge.
30% isolates resistance to ampicillin and sulfonamides Increasing of resistance to TMP-SMX Resistance to nitrofurantoin is <5% Resistance to fluoroquinolones <5% 3% resistant to TMP-SMX 0% resistant to nitrofurantoin 0.4% resistant to ciprofloxacin
S.saprophyticus
TMP-SMX
and frequency with a midstream culture containing < 10(5) CFU/mL. > 10(2) CFU/mL in women with acute symptomatic pyuria = UTI Tx as an uncomplicated UTI Mycoplasma genitalium, Ureaplasma urealyticum
abnormalities (polycystic, solitary, transplant kidney;DM, CRF, indwelling cath, neurogenic bladder) or elderly, male, child, pregnant or h/o recurrent UTI) E.coli accounts for fewer than one third of complicated cases.
Clinically, the spectrum of complicated UTIs may
agent with a broad spectrum of activity against the expected uropathogens: fluoroquinolone, ceftazidime, cefepime, aztreonam, imipenemcilastatin. (Obtain Ucx prior to Tx) Tx x 7-14 days Follow-up urine culture should be performed within 14 days after treatment???
Recurrent Cystitis
Up to 27% of young women with acute cystitis
develop recurrent UTIs. The causative organism should be identified by urine culture. Relapse: infection with the same organism (multiple relapses = complicated UTIs). Recurrence: infection with different organisms.
Recurrent Cystitis
>3 UTI recurrences documented by urine Cx within
one year can be managed using one of three preventive strategies: 1. Acute self-treatment with a three-day course of standard therapy. 2. Postcoital prophylaxis with one-half of a TMP-SMX double-strength tablet (80/400 mg). 3. Continuous daily prophylaxis TMP-SMX one-half tablet per day (40/200 mg); nitrofurantoin 50 to 100 mg per day; norfloxacin 200 mg per day.
Uncomplicated Pyelonephritis
Suspect if:
Cystitis-like
pain Severe illness with fever, chills, nausea, vomiting, abdominal pain Gram-negative bacteremia.
Uncomplicated Pyelonephritis
DX: Clinical, confirm with:
UA:
pyuria and/or WBC casts UCx with > 10 (5) CFU/mL (80%)
Tx: 14 days total
Oral:
Uncomplicated Pyelonephritis
Pt with symptoms after 3 days of
UTI in Men
At risk: Older men with prostatic
disease, UT instrumentation, anal sex, or partner colonized with uropathogens. UCx: 10 (3) CFU/mL sensitivity and specificity 97%. Additional studies?
Not
UTI in Men
Tx:
Uncomplicated
cystitis:
Complicated
cystitis:
Bacterial
prostatitis:
Catheter-Associated UTI
Risk of bacteriuria is ~ 5%/day (long
term catheter bacteriuria is inevitable). 40% of nosocomial infections Most common source of gram-negative bacteremia. Dx: Ucx 10 (2) CFU/mL
MO:
Catheter-Associated UTI
Mild to mod: oral quinolones10-14days
Severe infection: IV/oral 14-21days Asymptomatic bacteriuria in pt with
an indwelling Foley should not be Tx unless they are immunosuppressed, have risk of bacterial endocarditis or pt who are about to undergo urinary tract instrumentation.
Asymptomatic Bacteriuria
UCx: > 10(5)CFU/mL with no symptoms
Three groups of pt with asymptomatic
Pregnant patients
Asymptomatic bacteriuria: two
consecutive voided urine specimens with isolation of the same bacterial strain >10(5) or a single cath urine specimen.
Nitrofurantoin
100mg BID x 5-7 days Amoxi/Clav 500mg BID or 250 TID x 7days Fosfomycin 3g PO x 1
Interstitial Cystitis
Frequency, urgency, urge incontinence
with periurethral and suprapubic pain on bladder filling that is improved by voiding. Terminal hematuria may be present. Etiology. Unclear (autoimmune, altered glycosaminoglycal layer, allergic)
Interstitial Cystitis
TX
Refer
Interstitial Cystitis
Intravesical therapies
Dimethyl
Sulfoxide instillations q1-2 wks BCG instilled q1wk x 6-8 wks Hyaluronic acid instilled q1wk x 4-6wk.